tirzepatide for sleep apnea fda approval approved apneaππ₯ #tirzepatide #zepbound #glp1 #weightloss #sleepapnea #drrudybestlife #anewyouwellnesscenter #glp1community Breakthrough Treatment for Obstructive Sleep
Description
In a landmark 40-week Phase 3 trial with 1,973 patients with type 2 diabetes, Tirzepatide at 5 mg, 10 mg, and 15 mg doses achieved 4-12 pounds greater weight loss than Semaglutide (1 mg)
Results: The proportion of adults with type 1 diabetes using insulin pumps increased from 10.0% in 2014 (total number of adults with T1D 31843) to 16.7% in 2021 (total number of adults with T1D 35574)
The good news: its usually temporary
SHORTAGE IS OVER
